Cargando…
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiators Protect G551D but Not ΔF508 CFTR from Thermal Instability
[Image: see text] The G551D cystic fibrosis transmembrane conductance regulator (CFTR) mutation is associated with severe disease in ∼5% of cystic fibrosis patients worldwide. This amino acid substitution in NBD1 results in a CFTR chloride channel characterized by a severe gating defect that can be...
Autores principales: | Liu, Xuehong, Dawson, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159205/ https://www.ncbi.nlm.nih.gov/pubmed/25148434 http://dx.doi.org/10.1021/bi501007v |
Ejemplares similares
-
Expression of ΔF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation
por: Dosanjh, Amrita, et al.
Publicado: (2009) -
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR
por: Zhang, Shaoyi, et al.
Publicado: (2018) -
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl(-) Current by Novel Hydroxypyrazolines
por: Park, Jinhong, et al.
Publicado: (2016) -
ΔF508 CFTR interactome remodeling promotes rescue of Cystic Fibrosis
por: Pankow, Sandra, et al.
Publicado: (2015) -
5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo
por: Zhang, Yueqiang, et al.
Publicado: (2015)